BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1157096)

  • 1. Differences in the incorporation of bromodeoxyuridine by human lymphoblastoid cell lines.
    Henderson EE; Strauss B
    Cell; 1975 Aug; 5(4):381-7. PubMed ID: 1157096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the ability of human lymphoblastoid lines to exclude bromodeoxyuridine and in their sensitivity to methyl methanesulfonate and to incorporated [3H]thymidine.
    Higgins NP; Strauss BS
    Cancer Res; 1979 Feb; 39(2 Pt 1):312-20. PubMed ID: 216485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Epstein-Barr virus in hybrid cells.
    Tsang KY; Hann WD
    J Natl Cancer Inst; 1977 May; 58(5):1295-301. PubMed ID: 192898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromodeoxyuridine dependence--a new mutation in mammalian cells.
    Davidson RL; Bick MD
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):138-42. PubMed ID: 4509645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis.
    Budzko DB; Lachmann PJ; McConnell I
    Cell Immunol; 1976 Mar; 22(1):98-109. PubMed ID: 1277295
    [No Abstract]   [Full Text] [Related]  

  • 6. Flow cytometric analysis of bromodeoxyuridine-substituted cells stained with 33258 Hoechst.
    Latt SA; George YS; Gray JW
    J Histochem Cytochem; 1977 Jul; 25(7):927-34. PubMed ID: 70460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homology between Burkitt herpes viral DNA and DNA in continuous lymphoblastoid cells from patients with infectious mononucleosis.
    Kieff E; Levine J
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):355-8. PubMed ID: 4360941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible "transformation" of bromodeoxyuridine-dependent cells by bromodeoxyuridine.
    Davidson RL; Horn D
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3338-42. PubMed ID: 4530304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent patterns of incorporation of bromodeoxyuridine and iododeoxyuridine in human colorectal tumor cell lines.
    Maybaum J; Burton EC; Shelton DA; Jing HW; Dusenbury CE; Ensminger WD; Stetson PL
    Biochem Pharmacol; 1991 Jun; 42(1):131-7. PubMed ID: 1829889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The study of human myeloid differentiation using bromodeoxyuridine (BrdU).
    Keoffler HP; Yen J; Carlson J
    J Cell Physiol; 1983 Jul; 116(1):111-7. PubMed ID: 6574132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluorometric analysis of cellular DNA following incorporation of bromodeoxyuridine.
    Swartzendruber DE
    J Cell Physiol; 1977 Mar; 90(3):445-53. PubMed ID: 67119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of tubuloreticular inclusions in human lymphoma cells (Raji line) related to S-phase treatment with halogenated pyrimidines.
    Hulanicka B; Barry DW; Grimley PM
    Cancer Res; 1977 Jul; 37(7 Pt 1):2105-13. PubMed ID: 861937
    [No Abstract]   [Full Text] [Related]  

  • 13. [Difference in enzymatic activity among lymphoblastoid lines of various origins: cancer of the nasal pharynx (NPC), Burkitt's lymphoma (BL), infectious mononucleosis, and normal subjects].
    Buissiére J; Nardon P; Desgranges C; Didier-Fichet ML; de Thé G
    C R Acad Hebd Seances Acad Sci D; 1973 Oct; 277(14):1417-20. PubMed ID: 4204044
    [No Abstract]   [Full Text] [Related]  

  • 14. Tracer dose and availability time of thymidine and bromodeoxyuridine: application of bromodeoxyuridine in cell kinetic studies.
    Böswald M; Harasim S; Maurer-Schultze B
    Cell Tissue Kinet; 1990 May; 23(3):169-81. PubMed ID: 2357716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations of the mechanism of decreased tumorigenicity of cells grown in BrdU.
    Rothschild H; Black PH
    J Cell Physiol; 1973 Apr; 81(2):217-24. PubMed ID: 4348555
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological and biochemical effects of bromodeoxyuridine and deoxycytidine on Syrian hamster melanoma cells.
    Kaufman ER; Davidson RL
    Somatic Cell Genet; 1978 Sep; 4(5):587-601. PubMed ID: 694730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromodeoxyuridine does not contribute to sister chromatid exchange events in normal or Bloom syndrome cells.
    van Wietmarschen N; Lansdorp PM
    Nucleic Acids Res; 2016 Aug; 44(14):6787-93. PubMed ID: 27185886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus.
    Blazar BA; Sutton LM; Strome M
    Cancer Res; 1983 Oct; 43(10):4562-8. PubMed ID: 6309371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitization of Chinese hamster V79 cells by bromodeoxyuridine substitution of thymidine: enhancement of radiation-induced toxicity and DNA strand break production by monofilar and bifilar substitution.
    Ling LL; Ward JF
    Radiat Res; 1990 Jan; 121(1):76-83. PubMed ID: 2300671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochemical population analysis of cell linesderived from Burkitt's lymphoma, infectious mononucleosis, and acute lymphoblastic leukemia.
    De Bault L; Gahrton G; Foley GE
    Exp Cell Res; 1971 Mar; 65(1):156-60. PubMed ID: 5280077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.